Basenese Lou 4
4 · ENDRA Life Sciences Inc. · Filed May 29, 2020
Insider Transaction Report
Form 4
Basenese Lou
Director
Transactions
- Purchase
Common Stock
2020-05-28$0.91/sh+10,000$9,100→ 89,068 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.89 to $0.92, inclusive. The reporting person undertakes to provide to ENDRA Life Sciences Inc. (the "Issuer"), any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.
- [F2]Includes unvested restricted stock units.